The following info is from the SEC Form DEF14A (annual meeting proxy) filed today. The percentage shown for each shareholder assumes that shareholder (but no one else) has exercised all options exercisable now or within 60 days. The data is as of March 19, 2004.
HolderStakeNotes
HBK 10.8% From 1/04 PIPE Genentech 4.3% From 2000 collaboration Weisbrod, Stuart 4.2% Merlin BioMed Group All GENR insiders 3.6% See #1610 for details BVF 3.2% From 5/03 PIPE
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”